Vijaya Diagnostic Centre Limited (NSE:VIJAYA) has intimated that it will host an earnings conference call for analysts and institutional investors on Friday, August 7, 2026, at 10:30 A.M. IST to discuss financial results for the first quarter ended June 30, 2026. The announcement was filed with the National Stock Exchange of India (NSE) and BSE Limited on July 28, 2026, pursuant to SEBI Regulation 30(2).
Key Highlights
- Vijaya Diagnostic Centre will conduct Q1FY27 earnings conference call on August 7, 2026, at 10:30 A.M. IST to present and discuss first quarter financial results ended June 30, 2026.
- The conference call will be moderated by JM Financial Institutional Securities Limited and will feature managing director and CEO Ms. Suprita Reddy, COO Mr. Siva Rama Raju Vegesna, CFO Mr. Narasimha Raju, and Head of Investor Relations Mr. Dhiren Gala.
- Dial-in numbers are available for domestic and international participants, with toll-free access for USA, UK, Singapore, and Hong Kong regions.
- Investors and analysts must dial in 10 minutes prior to the scheduled start time to ensure timely connection to the conference call.
- Participants are advised that the management discussion may include forward-looking statements subject to risks and uncertainties that could differ materially from actual results.
About the Company
Vijaya Diagnostic Centre Limited is a diagnostic services provider listed on the National Stock Exchange of India under ticker VIJAYA (BSE code: 543350). The company operates a chain of diagnostic centres offering medical imaging, laboratory testing, and related healthcare diagnostic services across India. Vijaya Diagnostic Centre serves patients through its network of imaging and laboratory facilities, combining advanced diagnostic technology with clinical expertise to deliver diagnostic results and patient care services in the healthcare sector.
Announcement in Detail
Vijaya Diagnostic Centre Limited has notified the stock exchange that it is hosting an earnings conference call scheduled for Friday, August 7, 2026, commencing at 10:30 A.M. IST. The call has been arranged by JM Financial Institutional Securities Limited to enable analysts, institutional investors, and market participants to discuss the company's financial performance for the first quarter of fiscal year 2027 (ended June 30, 2026). This notification has been filed in compliance with Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to promptly inform stock exchanges of material events and decisions.
The management team participating in the earnings call includes Ms. Suprita Reddy (Managing Director and Chief Executive Officer), Mr. Siva Rama Raju Vegesna (Chief Operating Officer), Mr. Narasimha Raju (Chief Financial Officer), and Mr. Dhiren Gala (Head of Investor Relations and Corporate Development). Universal dial-in numbers have been provided: +91 22 6280 1366 and +91 22 7115 8267 for India-based participants. International toll-free numbers are available for USA (1 866 746 2133), UK (0 808 101 1573), Singapore (800 101 2045), and Hong Kong (800 964 448). A Diamond Pass Link has also been made available for direct connection. Participants are required to dial in 10 minutes before the scheduled time to ensure proper connection.
The announcement includes a standard safe harbour clause cautioning that management discussion and comments may include forward-looking statements concerning plans, objectives, strategies, and future events. All forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those contemplated. Conference call participants are advised not to place undue reliance on such forward-looking statements. The notification was signed by Ms. Naga Vasudha Tadepalli, Company Secretary and Compliance Officer (ICSI Membership No. A23711), on July 28, 2026.
Impact on Investors
The earnings conference call provides investors and analysts with a formal platform to hear directly from Vijaya Diagnostic Centre's senior management regarding the company's operational and financial performance for Q1FY27. Investors will note that this call offers an opportunity to clarify questions about quarter-on-quarter business trends, cost management, patient volumes, service mix, and strategic initiatives in the diagnostic services sector. The participation of the CFO and Head of Investor Relations in the call indicates management's commitment to transparent communication with market participants about financial performance and business developments.
For retail and institutional investors holding or tracking Vijaya Diagnostic Centre shares, attending or reviewing the call transcript post-event can provide factual context for the company's reported results when they are formally announced. The filing shows that the call is structured to permit two-way engagement with participants across multiple geographies, which investors will recognize as standard practice for listed companies to ensure accessibility and equal information dissemination. Investors should note that while the call will discuss Q1FY27 results, any forward-looking commentary made during the call remains subject to execution risks and market conditions.
Sector / Market Context
Diagnostic services in India operate within the broader healthcare sector and have seen steady growth as healthcare access expands and diagnostic imaging and laboratory testing become routine components of patient care. India's diagnostic services market comprises imaging centres, pathology laboratories, and integrated diagnostic chains serving both institutional and retail patient segments. The sector is characterized by capital-intensive operations requiring investment in imaging equipment, technology infrastructure, and skilled personnel. Listed diagnostic service providers regularly host earnings calls to discuss quarterly performance metrics such as centre utilization, service volumes, revenue per test, and margin trends that investors use to assess operational efficiency and profitability in the sector.